Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Abiraterone Acetate in Prostate Cancer
NCT01088529Phase 2Completed
- Sponsor
- Cougar Biotechnology
- Start
- Dec 2009
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Abiraterone Acetate Tablets (I) in prostate cancer (PCa) (2 arms), sponsored by Cougar Biotechnology. Primary endpoint: Number of Participants With a Pathology Tumor Stage of Less Than or Equal to Prostate Cancer Stage at Which the Tumor is Confined to the Prostate (pT2). Started Dec 2009; status: completed.
02
Drugs
Abiraterone Acetate Tablets (I)
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01088529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01088529.